Document Detail


The role of excessive volume expansion in the pathogenesis of preeclampsia.
MedLine Citation:
PMID:  16814939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Preeclampsia is a disorder which is responsible for significant maternal morbidity and mortality as well as fetal wastage. Its pathogenesis remains obscure and its only treatment is the delivery of the placenta and the fetus. Over time it has become clear that this syndrome is not a single disease but a disorder with, most likely, multiple etiologic factors that have a common (or similar) phenotype(s). A leading hypothesis, first developed in the early 1970s, is that the hypertension, proteinuria and intrauterine growth restriction are the result of hypoperfusion of the maternal-fetal unit. However, the early events leading to this deranged circulatory event have not been extensively studied. We hypothesize that at least one of the early pathogenetic events is excessive expansion of the extracellular fluid volume. This leads to persistent elaboration of (a) circulating factor(s) that interfere(s) with remodeling of the decidual vasculature preventing normal placentation from occurring. Our experiments have dealt largely with the role that an endogenous bufadienolide, marinobufagenin (MBG), plays in this pathogenetic process. In this report, we provide evidence for this thesis and point to future studies aimed at testing this hypothesis. These will include evaluating large groups of preeclamptic patients to determine their blood and urinary levels of MBG. Efforts will also be made to determine if there are differences in sodium handling in those patients with elevated levels of MBG, compared to other preeclamptic patients and to normal pregnant subjects.
Authors:
Jules B Puschett
Related Documents :
15082899 - Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms wit...
2147849 - Hypertension due to renal artery stenosis in pregnancy--the use of angioplasty.
20642319 - Increased placental telomerase mrna in hypertensive disorders of pregnancy.
12536339 - The m235t variant of the angiotensinogen gene and the body mass index are useful marker...
7438669 - Management of the hypertensive pregnant patient.
7687229 - Tumor markers in hypertensive disorders of pregnancy.
12592569 - Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos.
11725739 - Successful enucleation of a necrotizing fibroid causing oligohydramnios and fetal postu...
7683199 - Elevated maternal serum afp and normal ultrasound: what next?
Publication Detail:
Type:  Journal Article     Date:  2006-07-11
Journal Detail:
Title:  Medical hypotheses     Volume:  67     ISSN:  1532-2777     ISO Abbreviation:  Med. Hypotheses     Publication Date:  2006  
Date Detail:
Created Date:  2006-09-06     Completed Date:  2009-05-20     Revised Date:  2009-05-22    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  1125-32     Citation Subset:  IM    
Affiliation:
Tulane University School of Medicine, Department of Medicine, Section of Nephrology and Hypertension, 1430 Tulane Avenue, SL-45, New Orleans, LA 70112, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure
Disease Models, Animal
Edema / etiology
Extracellular Fluid / physiology
Female
Fetal Growth Retardation / etiology
Humans
Hypertension / epidemiology
Incidence
Placenta / pathology,  physiopathology
Pre-Eclampsia / epidemiology,  genetics,  pathology,  physiopathology*
Pregnancy
Pregnancy Complications / epidemiology,  physiopathology
Sodium / metabolism
Chemical
Reg. No./Substance:
7440-23-5/Sodium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of t...
Next Document:  Stem cells: new cell source for myocardial constructs tissue engineering.